PD-L1 expression is key to effector T cell regulation during disease pathogenesis; thus, tumour cells expressing PD-L1 use the PD-1-PD-L1 pathway as a mechanism to evade recognition/destruction by the immune system by suppressing effector T cell killing of tumour cells. The gene discussed is CD274; the disease is neoplasm.